论文部分内容阅读
目的评价疏血通联合胞二磷胆碱注射液治疗急性脑卒中的临床疗效。方法选择急性脑卒中且不宜溶栓患者42例,随机分为治疗组和对照组,在常规抗血小板聚集、降血压、降血脂等治疗基础上,治疗组以疏血通和胞二磷胆碱注射液静滴14 d;对照组予以丹参注射液和吡拉西坦氯化钠注射液静滴l4 d;观察两组的临床疗效及Glasgow评分、MMSE评分等变化。结果治疗组总有效率95.4%,高于对照组80.0%(P<0.05)。结论疏血通联合胞二磷胆碱注射液治疗急性脑卒中临床疗效肯定,能改善患者意识、智能及预后。
Objective To evaluate the clinical efficacy of Shuxuetong combined with citicoline injection in the treatment of acute stroke. Methods Forty-two patients with acute stroke who were not suitable for thrombolysis were randomly divided into treatment group and control group. On the basis of routine anti-platelet aggregation, blood pressure lowering and hypolipidemic treatment, the treatment group was treated with Shuxuetong and citicoline The rats in the control group were given intravenous infusion of Danshen injection and piracetam sodium chloride for 14 days. The clinical efficacy, Glasgow score and MMSE score of the two groups were observed. Results The total effective rate in the treatment group was 95.4%, higher than that in the control group (80.0%, P <0.05). Conclusion Shuxuetong combined citicoline injection in the treatment of acute stroke clinical efficacy of positive, can improve patient awareness, intelligence and prognosis.